99 related articles for article (PubMed ID: 18472419)
1. Postmastectomy locoregional recurrence and distant metastasis in breast carcinoma patients.
Yildirim E; Berberoglu U
Breast; 2008 Aug; 17(4):367-71. PubMed ID: 18472419
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
3. Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?
Yildirim E; Berberoglu U
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1024-9. PubMed ID: 17398017
[TBL] [Abstract][Full Text] [Related]
4. Locoregional recurrence in breast carcinoma patients.
Yildirim E
Eur J Surg Oncol; 2009 Mar; 35(3):258-63. PubMed ID: 18644692
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence in breast carcinoma patients with T(1-2) and 1-3 positive nodes: indications for radiotherapy.
Yildirim E; Berberoglu U
Eur J Surg Oncol; 2007 Feb; 33(1):28-32. PubMed ID: 17123771
[TBL] [Abstract][Full Text] [Related]
6. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
7. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation.
Jagsi R; Raad RA; Goldberg S; Sullivan T; Michaelson J; Powell SN; Taghian AG
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1035-9. PubMed ID: 15990006
[TBL] [Abstract][Full Text] [Related]
8. Locoregional recurrence after mastectomy: incidence and outcomes.
Buchanan CL; Dorn PL; Fey J; Giron G; Naik A; Mendez J; Murphy C; Sclafani LM
J Am Coll Surg; 2006 Oct; 203(4):469-74. PubMed ID: 17000389
[TBL] [Abstract][Full Text] [Related]
9. Triple negative phenotype and N-ratio are important for prognosis in patients with stage IIIB non-inflammatory breast carcinoma.
Mersin H; Yildirim E; Berberoglu U; Gulben K
J Surg Oncol; 2009 Dec; 100(8):681-7. PubMed ID: 19798691
[TBL] [Abstract][Full Text] [Related]
10. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.
Abramowitz MC; Li T; Morrow M; Sigurdson ER; Anderson P; Nicolaou N; Freedman G
Am J Clin Oncol; 2009 Feb; 32(1):30-3. PubMed ID: 19194121
[TBL] [Abstract][Full Text] [Related]
11. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy.
Truong PT; Lee J; Kader HA; Speers CH; Olivotto IA
Eur J Cancer; 2005 Jun; 41(9):1267-77. PubMed ID: 15939262
[TBL] [Abstract][Full Text] [Related]
12. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
Truong PT; Woodward WA; Thames HD; Ragaz J; Olivotto IA; Buchholz TA
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):59-65. PubMed ID: 17321065
[TBL] [Abstract][Full Text] [Related]
13. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer.
Tanis E; van de Velde CJ; Bartelink H; van de Vijver MJ; Putter H; van der Hage JA
Eur J Cancer; 2012 Aug; 48(12):1751-6. PubMed ID: 22446021
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329
[TBL] [Abstract][Full Text] [Related]
15. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
[TBL] [Abstract][Full Text] [Related]
16. Locoregional recurrence after management of carcinoma breast.
Farid G; Rasool MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):218-20. PubMed ID: 15857594
[TBL] [Abstract][Full Text] [Related]
17. Locoregionally recurrent breast cancer: incidence, risk factors and survival.
Clemons M; Danson S; Hamilton T; Goss P
Cancer Treat Rev; 2001 Apr; 27(2):67-82. PubMed ID: 11319846
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.
Yildirim E; Berberoglu U
World J Surg; 2007 Feb; 31(2):276-89. PubMed ID: 17219275
[TBL] [Abstract][Full Text] [Related]
19. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.
de Bock GH; Putter H; Bonnema J; van der Hage JA; Bartelink H; van de Velde CJ
Breast Cancer Res Treat; 2009 Sep; 117(2):401-8. PubMed ID: 19148746
[TBL] [Abstract][Full Text] [Related]
20. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Mansell J; Monypenny IJ; Skene AI; Abram P; Carpenter R; Gattuso JM; Wilson CR; Angerson WJ; Doughty JC
Breast Cancer Res Treat; 2009 Sep; 117(1):91-8. PubMed ID: 19112615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
